| Drug General Information |
| Drug ID |
D05TEW
|
| Former ID |
DNC002566
|
| Drug Name |
(4e)-4-Aminohex-4-Enoic Acid
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C6H11NO2
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
4-aminobutyrate aminotransferase, mitochondrial |
Target Info |
Inhibitor |
[1]
|
|---|
|
BioCyc Pathway
|
GABA shunt
|
|
Valine degradation
|
|
Beta-alanine degradation
|
|
4-aminobutyrate degradation
|
|
KEGG Pathway
|
Alanine, aspartate and glutamate metabolism
|
|
Valine, leucine and isoleucine degradation
|
|
beta-Alanine metabolism
|
|
Propanoate metabolism
|
|
Butanoate metabolism
|
|
Metabolic pathways
|
|
GABAergic synapse
|
|
PANTHER Pathway
|
Aminobutyrate degradation
|
|
Pyrimidine Metabolism
|
|
Gamma-aminobutyric acid synthesis
|
|
PathWhiz Pathway
|
Aspartate Metabolism
|
|
Glutamate Metabolism
|
|
Beta-Alanine Metabolism
|
|
Valine, Leucine and Isoleucine Degradation
|
|
Propanoate Metabolism
|
|
WikiPathways
|
GABA synthesis, release, reuptake and degradation
|
|
Alanine and aspartate metabolism
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
